Skip to main content

Table 1 Results for serum tumour marker and immune antibody levels

From: Lung adenocarcinoma discovered during the follow-up of lung-dominant connective tissue disease: a case report and literature review

Tumour markers

Result

Normal range

Immune

antibodies

Result

Normal range

CEA (ng/mL)

7.88

< 5

RF

< 10Ku/L

0-20IU/ml

NSE (ng/ml)

27.50

15.7–17.0

anti-Ku antibody

(-)

 

ProGRP (pg/mL)

115.8

0–46

anti-PM-SCL100 antibody

(-)

 

CA211 (ng/mL)

4.97

0-3.3

anti-PM-SCL75 antibody

(-)

 

SCC-Ag (ng/mL)

1.00

0-1.5

anti-Jo-1 antibody

(-)

 

CA125 (U/mL)

104.1

0–35

anti-SRP antibody

(-)

 

CA724 (U/mL)

4.51

0 ∼ 6.7

anti-PL-7 antibody

(-)

 

CA199 (U/mL)

658.8

0–37

anti-PL-12 antibody

(-)

 

CA242 (U/mL)

61.1

0–20

anti-EJ antibody

(-)

 

AFP (ng/mL)

3.67

< 25

anti-Ro-52 antibody

(+)

 
   

anti-CCP antibody

(-)

 
   

anti-SSA antibody

(±)

 
   

anti-SCL-70 antibody

(-)

 
   

anti-SSB antibody

(-)

 
   

anti-Mi-2 antibody

(-)

 
   

anti-dsDNA

24.3IU/mL

0-10IU/ml

   

C-ANCA

(-)

 
   

P-ANCA

(-)

 
   

anti-RNP

(-)

 
  1. alpha fetoprotein, AFP; anti-neutrophil cytoplasmic antibody, ANCA; anti-double stranded DNA antibody immunoglobulin G, dsDNA IgG; carcinoembryonic antigen, CEA; carbohydrate antigen 125, CA125; carbohydrate antigen199, CA199; carbohydrate antigen724, CA724; carbohydrate antigen242, CA242; cytokeratin 19 fragment, CA211; neuron-specific enolase, NSE; pro-gastrin-releasing peptide, ProGRP; rheumatoid factor, RF; squamous cell carcinoma antigen, SCCA